CUE
CUE
NASDAQ · Biotechnology

Cue Biopharma Inc

$17.50
-1.16 (-6.22%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target -10.0% upside
Low Target $10.91
Average Target $15.75
High Target $18.65
Current Price $17.50
Current
$17.50
Target
$15.75
$10.91 $15.75 avg $18.65
Scenario Analysis
Bear Case
$10.91
-37.7%
Low target
Base Case
$15.75
-10.0%
Avg target
Bull Case
$18.65
+6.6%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$45.50
-61.5% from high
52-Week Low
$4.97
+252.1% from low
Target vs 52W High
$15.75
-65.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%